Main Subject - Business

Negotiating with a mad man looks difficult, but it is not really. First never get suck

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ed into their game, always watch their actions and stop listening to their rhetoric. O

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ften you will see fear, anger and other emotions, which indeed are the easiest to mani

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

pulate to serve your will. If you have a problem with manipulations of feelings of a h

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

uman being who is crazy, nuts and a borderline lunatic then perhaps you should not be

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

involved in such negotiation. But if you do it can be quite fun and you should expect

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

to enjoy it really.

When negotiating with a mad man, tell them you agree with them, n

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

o matter what bizarre line of reasoning, tact or perspective they spin. This way you c

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

an play good guy for a minute and see if you can get them to argue against their own p

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

oints. If so this means they just like conflict and have been mirroring what they beli

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ve to be your insincerity.

If they just want to be argumentative and debate, then the

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

y are enjoying this process and therefore so should you too. Once they switch their po

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

sition to argue against your reversal of their perception of your opinion or stance. T

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

hen repeat back to them their original position in the debate. If they become more fie

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ry, say; Wait a minute. So what you are saying is; and repeat back their new stance. T

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

hen say but you also see the other side of the fence and repeat back their first point

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

s once again.

Next say, I sure learned a lot from you, you know you are alright, this

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

is very interesting. Next change the subject and ask them about something else and th

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

eir opinion. Then lead the conversation back to the first point of contention. Now you

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

are well on your way to negotiating with a perceived lunatic or the President of Iran

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/31215/mainsubjects-Negotiating-with-a-Mad-Man-Part-I.html">Negotiating with a Mad Man: Part I</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/31215/mainsubjects-Negotiating-with-a-Mad-Man-Part-I.html]Negotiating with a Mad Man: Part I[/url]

Do you own a business in Canada? Do you need business financing? Read this article to learn about factoring and purchase order financing.

Many people, under financial or other pressures to find work quickly, feel they can’t afford to take the time to get organized. On the other hand, conducting your job search in an organized manner wi...

Giving birth to a baby, and a business at the same time, appears to be a crazy idea, to those who haven't tried it. Come to think of it, even those of us who have embarked on this daunting double whammy, agree that there are easier ways to live your life. Read on for advice on how to make this feat achievable...

Tags

Links

Main Subject - Negotiating with a Mad Man: Part I

Related Articles: